All In Biotech

Free tool

FAERS Monitor: Somavert

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021106 or its brand name (Somavert, Pegvisomant). Reports on generic versions are filed under their own applications.

Reports

4,106

Serious

2,291

56% of reports

Hospitalization

801

Death reported

320

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use491
  • drug ineffective438
  • headache404
  • fatigue387
  • insulin-like growth factor increased380
  • arthralgia300
  • product dose omission issue268
  • injection site pain261
  • diarrhoea256
  • nausea231
  • pain213
  • blood pressure increased206
  • needle issue204
  • product use issue203
  • malaise201

Reports by year received

View as table
YearReports
200423
200535
200639
200722
200823
200938
201088
201173
2012102
2013156
2014164
2015176
2016181
2017276
2018382
2019402
2020354
2021245
2022350
2023455
2024261
2025196
202665

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,053 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
insulin-like growth factor increasedSignal3801860.71661.3516,887
needle issueSignal20436.131.66,896
blood pressure increasedSignal2066.96.01,042
product use issueSignal2035.54.8756
product dose omission issueSignal2684.74.2780
injection site painSignal2614.43.9682
arthralgiaSignal3003.73.3599
headacheSignal4043.33.0666
off label useSignal4912.92.6623
fatigueSignal3872.52.3376
malaiseSignal2012.32.1157
diarrhoeaSignal2562.01.8137
pain2131.81.674
drug ineffective4381.71.6135
nausea2311.51.339

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.